How big is the interventional oncology market?

The global interventional oncology market size was valued at USD 5.19 billion in 2023 and is anticipated to reach around USD 13.82 billion by 2033

Who are the key players in interventional oncology market?

Some key players operating in the interventional oncology market include Medtronic plc; Boston Scientific Corporation; Johnson & Johnson (Ethicon); Baxter International Inc.; Cook Medical; C.R. Bard Inc. (Acquired by BD); AngioDynamics Inc.; Stryker Corporation; B. Braun Melsungen AG; Terumo Corporation; Siemens Healthineers; GE Healthcare.

What are the factors driving the interventional oncology market?

Key factors that are driving the market growth include prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology.

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Application, By End-use, By Region)- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

Report Details

Report Code:8732
Category:Healthcare
No. of Pages:250+
Format:PDF/PPT/Excel
Published:April 2025
Historical Year:2021-2023
Base Year:2024
Estimated Year:2025-2034

Get a Sample

Proceed To Buy

Global Deep Dive Analysis

USD 4500

Single Region (NA,EU,APAC,LA,MEA)

USD 3900

Databook

USD 1900

Competitive Intelligence

USD 1200

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others

Ask To Expert